SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM)
6 references·0 citing·31 second hop
Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) (2017)Five-Year Cost-effectiveness of the Multi…The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention (2012)The 10-Year Cost-Effectivenes…Cost-effectiveness of a Multicondition Collaborative Care Intervention (2012)Cost-effectiveness of a Multi…Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis (2010)Delivering the diabetes educa…Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes (2003)Within-Trial Cost-Effectivene…Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) (2000)Cost effectiveness of an inte…An Assessment of Clinically Useful Measures of the Consequences of Treatment (1988)An Assessment of Clinically U…The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force (2015)The Cost of Diabetes Care—An Elephant in the Room (2018)Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review (2020)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia (1997)Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. (2002)The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) (2003)Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (2006)Eliciting preferences for alternative drug therapies in oncology: Influence of treatment outcome description, elicitation technique and treatment experience on preferences (1987)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Analysing Data and Undertaking Meta‐Analyses (2008)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Cost-Effectiveness in Health and Medicine (1996)The PHQ-9 (2001)Collaborative Care for Depression (2006)Mental Health Collaborative Care and its Role in Primary Care Settings (2013)Collaborative Care for Adolescents With Depression in Primary Care (2014)Urgent Need for Improved Mental Health Care and a More Collaborative Model of Care (2017)Modeling Valuations for EuroQol Health States (1997)A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) (2004)A taxonomy of model structures for economic evaluation of health technologies (2006)Emotional and Behavioral Problems Among Adolescent Students: The Role of Immigrant, Racial/Ethnic Congruence and Belongingness in Schools (2012)Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation (2020)Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? (2020)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians (2007)Health Psychology: The Search for Pathways between Behavior and Health (2007)
this work references cited by second hop

References

  • 1988An Assessment of Clinically Useful Measures of the Consequences of Treatment1,691 cited
  • 2012The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention435 cited
  • 2000Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)322 cited
  • 2012Cost-effectiveness of a Multicondition Collaborative Care Intervention291 cited
  • 2003Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes262 cited
  • 2010Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis251 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work